Important step forward in osteoarthritis research: bioactive collagen peptides stimulate the regeneration of cartilage tissue

Montreal, Canada / Kiel, Germany, 12 September 2009. Working in collaboration with Kiel University, researchers at the Kiel-based Collagen Research Institute (CRI) have demonstrated the stimulating effect of special bioactive collagen peptides (FORTIGEL®) in the context of cell experiments. In September the CRI presented its research findings at the congress of the Osteoarthritis Research Society International (OARSI) in Montreal. The investigations of the CRI provide an explanation for the findings of a joint clinical trial carried out by Harvard Medical School and Tufts Medical Center – likewise presented at the congress. With the aid of special imaging (MRI) techniques this clinical trial demonstrated that FORTIGEL® stimulated cell metabolism in the knee-joint cartilage and promotes the regeneration of cartilage tissue.

MORE

GELITA wins Frost & Sullivan Award "European Health Ingredient of the Year 2008"

New product FORTIGEL® honored as an outstanding pioneer development for healthy joints – excellent market chances for applications in nutrition and medicine

A real breakthrough in joint health: GELITA has developed an ingredient - FORTIGEL® - that clearly brings about regeneration of joint cartilage. FORTIGEL® is thus the first food ingredient for the maintenance of healthy joints and the treatment of osteoarthritis. For this excellent pioneer work, GELITA has been awarded the Frost & Sullivan "European Health Ingredient of the Year Award 2008".

MORE